Moderna Inc (MRNA) — Cash Flow Quality Index
Moderna Inc (MRNA) has a Cash Flow Quality Index of -120.46x as of September 2024. Operating cash flow of $-1.57 Billion is below net income of $13.00 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Moderna Inc cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Moderna Inc Cash Flow Quality Index (2021–2022)
Historical Cash Flow Quality Index for Moderna Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Moderna Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Moderna Inc (2021–2022)
Year-by-year earnings quality comparison for Moderna Inc. For live market cap and the full company financial profile, see Moderna Inc stock valuation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 0.60x | $4.98 Billion | $8.36 Billion | ▼ -46.6% |
| 2021 | 1.12x | $13.62 Billion | $12.20 Billion | — |